SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-144016
Filing Date
2012-03-30
Accepted
2012-03-30 17:19:07
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d286951d10k.htm 10-K 685172
2 EX-10.6 d286951dex106.htm EX-10.6 83348
3 EX-21.1 d286951dex211.htm EX-21.1 1563
4 EX-23.1 d286951dex231.htm EX-23.1 1909
5 EX-31.1 d286951dex311.htm EX-31.1 9399
6 EX-32.1 d286951dex321.htm EX-32.1 4187
  Complete submission text file 0001193125-12-144016.txt   2778625

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ljpc-20111231.xml EX-101.INS 408545
8 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20111231.xsd EX-101.SCH 12578
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ljpc-20111231_cal.xml EX-101.CAL 20445
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ljpc-20111231_def.xml EX-101.DEF 16025
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20111231_lab.xml EX-101.LAB 114434
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20111231_pre.xml EX-101.PRE 70542
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 12730378
SIC: 2836 Biological Products, (No Diagnostic Substances)